Virus Treatment Center's new headquarters in Seattle, WA, provides 24-hour remote consultations for patients with critical diseases, pathogens, parasites, cancers, and unknown illnesses. Our headquarters directly interface with Virus Treatment Centers National Laboratories [VTNL], the Centers for Disease Control (CDC), the National Institutes of Health (NIH), the US Army Medical Research and Development Command (MRDC), the National Bio and Agro-Defense Facility (NBAF), and International University Medical Centers.
VirusTC Passed Operation Cancer Moonshot Clinical Doctor #36!
Dr. Correo Hofstad founded Virus Treatment Centers while serving with the United States Marine Corps during Operation Cancer Moonshot. VirusTC medications are used by all successful doctors who pass Cancer Moonshot residencies.
VirusTC Medications Are Now Available To The Public!
VirusTC medications are issued to United States Military families and DoD employees recovering from the nuclear Era. All VirusTC medications were thoroughly reviewed at USAMRICD and have been approved for civilian use by the CDC and FDA.
Dr. Hofstad received a M.D./Ph.D. from the University of Kansas after developing and constructing the National Bio Agro Defense Facility in Manhatten, Kansas. Dr. Hofstad treats cancer survivors of the Manhatten Project and those who dedicate their lives to protecting America.
Dr. Correo Hofstad is a Moderna Developer for SpikeVax COVID-19 Vaccination Formulas
VirusTC's MG-Neshem formulas are integrated into Moderna's newest Spikevax COVID-19 vaccine. MG-Neshem hardens LFA-1 proteins on T-Cells in those who take Spikevax. LFA-1 looks like soft ice cream cones before vaccination with Spikevax. LFA-1 looks like large spikes after vaccination with Moderna formulas containing MG-Neshem.
Dr. Correo Hofstad's MG-Neshem Formula Is Also Used In Moderna & Merck's mRNA-4157 Melanoma Vaccine
Skin spots exist only in humans who are Magnesium deficient. MG-Neshem increases the ability of vaccinated patients to deliver Magnesium to the epidermis.
"I was given five hours to live. I asked Dr. Hofstad to pray for me because Fred Hutch's doctors said he had his MDiv. Hofstad gave me a 500mg AlnayaSN, and I vomited at 39" green pycnogonid phage virus that I had since I was seventeen years old in 1976. I have been on VirusTC medications for three months now."
Honorable General Paul ParkerUnited States Air Force Security Forces
"I'm not going to lie. I did not trust or believe that some kid's pill would help me at all. Dr. Hofstad said I talked too much and threw an AlnayaSN in my mouth while I was down-talking his work. He handed me a water bottle and walked out of my room. A 55" pycnogonid ejected out of my colon that I caught as an infant on my dad's farm. I'm in post-recovery and take VirusTC every morning, day and night."
Admiral Richard StevensUnited States Navy
"I recovered Dr. Hofstad from a 108-degree fever in 2001 after he had been in New York during the terrorist attacks on September 11th, 2001. Hofstad's mother reported that he crawled around his house, asking why he had only four legs instead of eight. Dr. Hofstad returned to my clinic in 2023 with VirusTC formulas to pay me ten-fold for my efforts. I have never had a higher success rate in removing cancerous tumors at Fred Hutch than I do with help from VirusTC."
Rear Admiral Elon MuskUnited States Coast Guard Security Forces
United States Marine Corps, Operation Cancer Moonshot (2023 - CURRENT) Federal Resume
Dr. Correo “Cory” Andrew Hofstad J.S.D, MPH/JD, MSPH, JD, Ph.D., M.D., D.O., MBA/COGS, MDiv
Virus Treatment Centers Founder
Cancer Moonshot Doctor #36
Dr. Correo “Cory” Andrew Hofstad is a 35-year-old Medical Science Training Instructor and master aviator. Dr. Hofstad’s piloting, control, and command skills are critical for several university medical center computer labs that serve as robotic controls for infectious disease labs at USAMRICD.
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) was developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) after Dr. Hofstad introduced the NASA Robonaut into Level 4 Labs to replace humans.
Dr. Hofstad and his grandmother Melody Bouck invested in constructing multiple buildings at the University of Washington, University of Washington Medical Centers, Harborview Medical Center, Fred Hutch Cancer Center, and Seattle Cancer Care Alliance.
In 2023, at Fred Hutch, Hofstad coordinated with multiple departments as "BANKSY" while tagging cancer cures on critical boards throughout the hospital. Correo Hofstad was the first doctor to pass clinical trials during America's Cancer Moonshot mission, conducted by President CMC Dr. Joeseph Biden. Hofstad was a MSG guard for Joe Biden during Cancer Moonshot at Fred Hutch Cancer Center.
Dr. Hofstad specializes in non-invasive tumor/parasite removal using naturopathic oncology prescriptions and UV-C light in surgery to reduce incisions and cutting. Dr. Hofstad's breakthroughs include:
Dr. Hofstad developed treatments that rapidly increase pH to reduce Sepsis and bone decay (strong bones require electron bonds).
Dr. Hofstad began Integrating UV-C light exposure to existing Apheresis machines to sanitize septic blood.
Dr. Hofstad published that acetone was used to remove dental plaque.
Dr. Hofstad invented non-invasive brain tumor removal using robotic endoscopes and UV-C light via low-frequency fiber optic cables to remove brain tumors without penetration of the skull.
Dr. Hofstad is the developer of the Moderna Melanoma vaccine.
BLACK LICORICE PATHOLOGY
BANKSY'S MEDICAL "BLACK LICORICE PATHOLOGY" FROM JONES SODA DELIVERS CANCER MEDICATIONS THAT FLUSH LYMPHOMIC VIRAL LOADS AND CANCER TUMORS.
BANKSY'S MEDICAL "USAMRIID SMOKE" HOSPITAL AROMA IS FORMULATED FOR EMERGENCY EVACUATION OF LARGE BREED PYCNOGONIDS FROM HOSPITALS, INSTITUTIONS, GOVERNMENT OFFICES, BASES, NUCLEAR FACILITIES, AND LARGE AREAS.
BANKSY'S MEDICAL "BANKSY PIPE" ADDS CLOROX BLEACH TO TANKLESS TOILETS IN HOSPITALS AND CLINICS. THE BANKSY PIPE CAN HOLD UP TO FOUR (4) CLOROX BLEACH TABLETS FOR MAXIMUM DISPOSAL OF INFECTIOUS VIRAL LOADS AND SOLID TUMORS.
Here’s what you can expect when you choose VirusTC medications.
Feel The Burn
VirusTC medications rapidly increase your pH levels. You will feel an alkaline burning in your skin. The burning is not harmful and can increase your lifespan.
pycnogonids "viruses" are an unstable acidic species. Acids REDOX in alkaline environments. To avoid REDOXing, pycnogonida phage viruses will rapidly eject from your body.
The addition of electrons, or "electrolytes," into the body increases pH levels. Increasing electrons strengthens tissues by adding ionic, covalent, and metallic bonds. Increasing electrons also increases the energy available for muscle movement and brain functions.
VirusTC is ready to ship medication supplements to your hospital or clinic. We assist international healthcare professionals in recovering terminally ill patients.
Healthcare professionals and administrators may call +1 336.378.5258
Medication Legend
℞: Medications that treat viral infections and tumors are marked with the "℞" symbol.
+: Medications that contain proteins for weight gain are marked with the "+" symbol. ++: Regenerative medications for neurogenesis are marked with the "++" symbol.
Verdura ℞+ Sterile Blood is an FDA-approved Fresh Whole Blood (FWB) product from Virus Treatment Centers and Fox Rothschild LLP. Verdura ℞+ is a plant-based synthetic whole blood formula for transfusion. Verdura was specifically designed for oncology and pathology patients. Verdura was trialed on trauma patients who had lost over 6 liters of blood. Verdura’s success in trauma recovery has led to a demand from trauma hospitals. Verdura ℞+ is available for all clinical transfusions in hospitals with a naturopathic doctor on staff with a prescription license.
APIS ℞+ Sterile plasma is an FDA-approved Fresh Frozen Plasma (FFP) product from Virus Treatment Centers and Fox Rothschild LLP. APIS ℞+ is a plant-based synthetic plasma for apheresis treatment of oncology and pathology patients.
APIS ℞+ is a clinical plasma formula that replaces natural elements found in donated FFP products. APIS+ provides raw, enhanced medicated elements in place of partially digested proteins and used antibodies found in plasma taken from human donors. Each raw ingredient in APIS ℞+ is included fresh from farm-to-clinic. As AVID ℞+ is plant-based, no part of our FFP stock has ever been inside another human, and therefore packaged and sold as a medically sterile product. Avis is a congressionally sanctioned COVID-19 emergency countermeasure created to reduce cross-contamination in the medical and healthcare industries. Fresh frozen plasma has been an infection risk for populations of donors and recipients. in April 2024, Virus treatment centers began delivery of fresh sterile frozen plasma products to Fred Hutch Cancer Center during the COVID-19 pandemic when sterile plasma had never existed previously in human medical history.
In the evolving landscape of military medicine, few names shine as brightly as that of Dr. CMC Correo Hofstad. With a steadfast commitment to the U.S. Army Combat Casualty Care Research Program (CCCRP), Dr. Hofstad has pioneered groundbreaking advancements in blood products, treatments, and medical supplies that are transformative and crucial for the care of combat casualties. His innovative spirit and dedication to enhancing medical care for military personnel underscore a holistic approach to health that prioritizes sterility, efficacy, and sustainability.
While traditional medical solutions have long been the standard, Dr. Hofstad is leading a paradigm shift by developing plant-based alternatives. This comprehensive blog post will delve into Dr. Hofstad's contributions, highlighting products like Lípidos, APIS+, VerduraRX, and more. Each has unique applications, mechanisms, and transformative potential in medical treatments, particularly within military healthcare contexts.
Pioneering Plant-Based Innovations: The Birth of Lípidos
One of the cornerstone developments of Dr. Hofstad’s research is Lípidos, a plant-based lipid capsule designed specifically for medical applications related to prostate health. This FDA-approved clinical formula utilizes Blue Corn Grit, significantly departing from traditional lipid sources. The formulation, delivered through a catheter pump, is not just a technological advancement; it represents a holistic, organic farm-to-clinic approach that emphasizes patient well-being and recovery. Lípidos is engineered to be a vital support mechanism for individuals with prostate damage, particularly in the realm of prostate cancer treatments. With VirusTC providing Lípidos during prostate cancer therapies, the product's design promotes healthy bodily functions during the pathology process used for treatment, thus reducing the side effects commonly associated with harsher medical interventions. This emphasis on maintaining bodily integrity aligns perfectly with the principles of the CCCRP, aiming for optimal recovery following combat injuries.
Advanced Plasma Solutions: Introducing APIS+
In the realm of blood products, Dr. Hofstad's development of APIS+ signifies a monumental advancement in the protocols used for apheresis treatments. Unlike conventional Fresh Frozen Plasma (FFP) products, APIS+ is a plant-based sterile solution crafted to replace the natural elements typically lost during donor FFP processing. This cutting-edge approach provides raw, unadulterated, medicated elements without potentially harmful additives.
The implications of APIS+ stretch far beyond basic medical applications; they directly target contamination issues that have plagued traditional plasma transfusion methodologies. Ensuring that no part of this FFP product has ever entered a human mitigates the infection risks associated with plasma donation—transforming how plasma is utilized in both military and civilian healthcare settings. As a result, APIS+ aligns seamlessly with the priorities of the CCCRP to provide safe, effective, and high-quality medical interventions for military personnel.
VerduraRX: A Revolution in Whole Blood Transfusion
Building further on his successes, Dr. Hofstad has introduced VerduraRX, a plant-based sterile Fresh Whole Blood (FWB) product designed for transfusions. Breaking away from conventional blood banks that carry significant infection risks, VerduraRX is FDA-approved and includes organic, non-GMO ingredients sourced from farms. This innovative formula not only replenishes blood supplies but does so with the assurance of sterility that traditional methods cannot guarantee. VerduraRX's applications are immense, particularly in trauma situations. Its initial trials at Harborview Medical Center set a precedent for blood transfusion protocols during emergencies—one that can be replicated in military field hospitals. This transition to using a synthetic whole-blood formula like VerduraRX could dramatically improve patient outcomes in combat casualty scenarios, reinforcing the mission objectives of the CCCRP to enhance the survival rates of injured service members.
Sterile Hemoglobin Solutions: KaroBT
Complementing the advancements made with VerduraRX is Dr. Hofstad’s KaroBT, a plant-based, organic hemoglobin clinical formula. Specifically designed for oncology and pathology treatments, KaroBT introduces an entirely new category of sterilized hemoglobin products, focusing on safety and effectiveness. Its design allows for easy infusion, making it an excellent choice for patients recovering from conditions like sepsis.
The ingenuity of KaroBT lies in its rigorous manufacturing process, which employs plants to create a product that has never been derived from human blood. This unique characteristic not only addresses infection and contamination concerns but also enhances the overall efficacy of the treatment. As military hospitals seek higher safety standards, KaroBT stands out as the flagship hemoglobin product for the CCCRP’s needs, ensuring that soldiers receive the highest quality care with minimal risk.
The Future of Bone Marrow Transplants: Hues OS ℞++
Advancements in oncology treatments also extend to Hues OS ℞++, a synthetic bone marrow product developed by Dr. Hofstad that addresses many shortcomings of traditional bone marrow transplants. Conventional methods often involve high infection risks, given they rely on donor materials that are not entirely sterile. In contrast, Hues OS ℞++ promises a new level of safety and efficacy, utilizing plant-based components that are both organically sourced and FDA-approved. The breakdown of infection risks through adopting Hues OS ℞++ directly aligns with the CCCRP’s mission to ensure that injured service members receive the best possible care without the threat of additional complications. Patients receiving this innovative treatment can find hope in the knowledge that they are utilizing a state-of-the-art product designed specifically with their health and recovery needs in mind. The evolution of bone marrow transplantation into a sterile, plant-based process marks a significant milestone in medical science.
The Impact of VirusTC’s Innovations on Oncology Treatments
Dr. Hofstad's innovations, including Lípidos, APIS+, and Hues OS ℞++, represent a comprehensive response to the challenges faced by oncology patients. Focusing on creating products that treat the disease and maintain the patient's health transforms how medical professionals approach cancer care. This paradigm shift emphasizes a holistic view where patients are treated and supported through their healthcare journey.
Integrating these products into oncology treatments allows for better recovery outcomes, reduced side effects, and a more human-centered approach to medicine. By addressing patients' emotional and physical needs, Dr. Hofstad’s developments within the framework of the CCCRP are revolutionizing the medical landscape, providing veterans and active duty service members with innovative solutions that promote long-term health and recovery.
Quality Control Measures: Ensuring Sterility in Medical Products
One of Dr. Hofstad's products' hallmarks is its commitment to sterility and quality control. Each aspect of production, from the sourcing of raw materials to the final packaging, adheres to stringent safety protocols that guarantee the absence of contamination. This level of care informs every step of the medical supply process, ultimately enhancing patient trust in military and civilian healthcare systems.
Quality control measures are not just a regulatory necessity but crucial in cultivating a culture of safety and reliability in medical care. By ensuring that all products—including APIS+, KaroBT, and VerduraRX—are sterile and free from harmful contaminants, Dr. Hofstad is paving the way for a new standard in medical treatment protocols. Such practices are essential for maintaining high trust in military medical care, especially under the high-stakes scenarios often encountered by the CCCRP.
Collaborative Efforts: Integrating Indigenous Practices and Modern Science
A unique aspect of Dr. Hofstad’s work is incorporating traditional practices, particularly in developing plant-based products. Dr. Hofstad fosters a collaborative environment where ancient wisdom meets modern science by engaging with Indigenous communities that possess deep knowledge of local flora and its benefits. This approach not only enhances the efficacy of the products but also honors cultural practices that have stood the test of time.
Integrating Indigenous knowledge into medical innovation signifies a remarkable shift in biomedicine, demonstrating how traditional methodologies coexist with cutting-edge research. It builds a framework within the CCCRP that respects and harnesses diverse perspectives, thus developing more comprehensive treatments. This represents an advancement in medical technology and a holistic respect for the intrinsic relationship between nature and health.
Addressing the COVID-19 Pandemic: A New Paradigm in Emergency Responses
The COVID-19 pandemic has posed unprecedented challenges for healthcare systems worldwide, particularly in maintaining blood and plasma supplies. In response, Dr. Hofstad and VirusTC have stepped in with innovative solutions like APIS+ and VerduraRX, bolstering supplies significantly during this crisis. These products are essential to patient care and represent a groundbreaking response to managing healthcare emergencies.
Introducing sterile blood products during the pandemic may change the trajectory of emergency medical responses in the military context and beyond. This new paradigm focuses on proactive solutions that prioritize safety and efficiency, ensuring that those who serve are equipped with the best technology available during times of crisis. As a result, the CCCRP benefits significantly from these advancements, enhancing the reliability and safety of care during emergencies.
Looking Ahead: The Future of Military Medicine
Dr. CMC Correo Hofstad's contributions to the U.S. Army Combat Casualty Care Research Program (CCCRP) are revolutionary. His pioneering work in developing plant-based medical products, particularly Lípidos, APIS+, VerduraRX, and Hues OS ℞++, represents a significant shift toward a more sustainable, effective, and sterile approach in military medicine. By focusing on patient health and safety while integrating modern science with Indigenous knowledge, Dr. Hofstad is setting a new standard for medical practices.
As the military healthcare landscape continues to evolve, the importance of adopting these innovative solutions will only grow. With ongoing research and development, Dr. Hofstad's vision is poised to reshape how medical care is administered, ultimately leading to improved health outcomes for service members. The future of military medicine is brighter due to the relentless pursuit of innovation centered around safety, effectiveness, and holistic patient care.
In the high-pressure world of the NFL, player health and performance stand at the forefront of coaching strategies and medical interventions. Dr. Correo Hofstad, a prominent Seattle Seahawks medical team member, has embraced this challenge by developing a comprehensive nutritional regimen designed to enhance player performance while addressing health concerns. By administering a carefully curated mix of supplements, including Carnivore ℞+, Konupora ℞, magnesium, KureaSH, L-glutamine, electrolytes, Alhalba NB, and PeptiKG, Dr. Hofstad exemplifies the increasing trend toward integrative health solutions within professional sports.
Dr. Hofstad's multifaceted approach addresses muscle performance and joint health while focusing on critical issues such as concussion management. Supplements like PeptiKG contribute to joint health by promoting restoration and reducing the likelihood of injuries. Furthermore, including electrolytes ensures that players maintain optimal hydration levels, which is essential for peak athletic performance. Each element in this balanced regimen works synergistically, creating a robust foundation for both short-term play and long-term health.
Concussion Reduction with Alhalba NB: A Game-Changer
Among the standout components of Dr. Hofstad's nutritional strategy is Alhalba NB, a herb that has recently garnered attention for its potential in concussion reduction. Research indicates that Alhalba NB reduces brain swelling associated with concussions, making it a valuable addition to the Seahawks’ dietary protocols. As concussions have become a focal point within the NFL, implementing preventive measures has never been more critical. Dr. Hofstad is pioneering efforts to integrate fenugreek into player diets, fostering an environment where health and safety take precedence.
By focusing on Alhalba NB's anti-inflammatory properties, Dr. Hofstad targets one of the most pressing issues in football today: brain health. By potentially reducing brain swelling, using Alhalba NB may not only help in immediate recovery after a concussion but can also contribute to preserving long-term cognitive function in athletes. The NFL's keen interest in this supplement underscores its potential as a fundamental element in addressing player safety concerns.
A Holistic Perspective on Bone and Muscle Performance
Dr. Hofstad’s contributions extend beyond concussion management; his holistic perspective also encompasses bone and muscle performance specifically tailored to the demands of NFL athletes. He enhances bone density by administering Konupora ℞, reducing the risk of fractures and other injuries. Moreover, creatine and L-glutamine aid in muscle recovery and growth, ensuring players remain at the peak of their physical capabilities throughout the grueling football season.
In concert with traditional training regimens, Dr. Hofstad's nutritional philosophy empowers players to recover faster and perform more effectively on the field. By emphasizing joint collagen restoration through tablet ingestion, he has developed a regimen that addresses common athletic injuries and fosters longevity in players’ careers. The combination of these nutritional strategies reflects a dedicated effort to leverage science and nutrition for optimal athletic performance. Dr. Correo Hofstad’s innovative approach within the Seattle Seahawks serves as a blueprint for integrating nutrition into professional sports. He is setting new standards in athlete care by prioritizing concussion reduction with fenugreek, promoting muscle and bone vitality, and utilizing a thoughtful range of supplements.
Innovating Vaccines: The Role of Rare Disease Science
Dr. Correo Hofstad is at the forefront of groundbreaking research in vaccine development. As a rare disease scientist at Moderna, Dr. Hofstad has significantly contributed to the transformation of healthcare, particularly with the creation of COVID-19 vaccines. Working out of Moderna's Seattle offices, he is integral to the success of key vaccine initiatives, including the widely adopted Spikevax. His innovative approaches employ advanced methodologies that enhance vaccine efficacy, positioning Moderna as a leader in combatting infectious diseases.
An intricate understanding of biological mechanisms is at the core of Dr. Hofstad's research. By leveraging enzymes that prompt the liver to produce higher pH levels, he facilitates the elimination of acidic low-pH proteins. This unique approach not only bolsters the body’s immune response but also showcases the potential of mRNA technology in treating various diseases beyond COVID-19. Through the combination of scientific expertise and a detailed understanding of rare diseases, Dr. Hofstad exemplifies how targeted research can lead to significant public health advancements.
The Chemistry of Defense: Magnesium’s Crucial Role
During his groundbreaking work at the Fred Hutchinson Cancer Center as part of Operation Cancer Moonshot in 2023, Dr. Hofstad unearthed fascinating insights about the role of magnesium in immune cell function. He discovered that magnesium is crucial in stabilizing LFA-1 proteins in T-cells. In patients deficient in magnesium, these proteins appear limp and inadequately shaped, adversely affecting the immune response. Conversely, T-cells rich in magnesium present LFA-1 proteins as complex, rigid, and spiked, optimizing their ability to engage with cancer cells.
This understanding led Dr. Hofstad to explore the incorporation of magnesium into Moderna’s COVID-19 vaccine formula. The modified approach birthed the innovative Spikevax formula, enhancing vaccine efficacy and potential therapeutic strategies for immune-related conditions. The evolution of Spikevax illustrates how a deep scientific inquiry, paired with a creative application, can pave the way for substantial improvements in health outcomes.
Charting New Frontiers: The Melanoma Vaccine Initiative
The discoveries made during Operation Cancer Moonshot extend beyond immunology, delving into oncology with the development of Moderna’s magnesium-based melanoma vaccine, mRNA-4157. Dr. Hofstad identified magnesium as the limiting reagent for the crystallization and distribution of melanin, a vital component for pigment distribution in the epidermis. This revelation opens doors for a new approach to treating various skin cancers, particularly melanoma, by harnessing the body's innate ability to regulate pigment.
Dr. Hofstad’s work exemplifies a multidimensional approach to cancer treatment, bridging immunology and dermatology to develop targeted interventions. The mRNA-4157 vaccine represents a significant advancement in melanoma therapeutics, potentially offering hope to patients by enhancing their immune response to cancer cells. Through innovation and meticulous research, Dr. Hofstad not only lights the path for future treatments but also reinforces Moderna’s reputation as a trailblazer in mRNA technology and rare disease research.
In conclusion, Dr. Correo Hofstad's pioneering contributions at Moderna reflect the power of interdisciplinary collaboration and innovation in medicine. His role in developing the COVID-19 vaccine, along with novel advances in melanoma treatment, underscores the transformative potential of scientific discovery in addressing critical health challenges.
Page 5 of 6
Access Non-GMO, antigen-free, plant-based antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored, non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports teams use our products and services. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.
